X-Message-Number: 1906
From: R. Ettinger
Subject: Replies From Ettinger

Robert Ettinger sent to me a reply to the CryoNet postings that
I sent to him.  (Since then, several more people have posted
messages that I need to forward to Ettinger.)  He also included
a detailed reply to Mike Darwin's feedback (which was posted as
message #1787) and gave the OK to forward his messages as I wish.
I have appended his replies below.
				      Kevin Q. Brown
				      
				      
-----
March 2, 1993

Dear Mr. Brown:

Thanks very much for the Cryonet copies.

Enclosed are my second letter, which you may or may not have seen, and
my response to Mike Darwin.  Following are my responses to some of the
comments you sent me.  You may use all this as you wish.

On the matter of convection (Steve Harris) : No doubt there will be
some convection, of a nature very hard to calculate.  But remember my
first stratagem in the first (Feb.  12) letter: we use buffers of
insulation around the patients where appropriate, to damp temperature
changes; and also an inside wrapping or pod of highly thermally
conducting material, that tends to equalize temperatures all around
the patient's surface.  What the net result will be can only, I think,
be determined by experiment, which is what we (Cryonics Institute) plan
to do, as time allows--using a cylindrical cryostat, which might allow
neuro storage by this system.  (CI does not do neuros, and at present
does not store them, but we still want the information.)

On the matter of stable top temperature (Brian Wowk) : There is
insulation at the top.  Nitrogen loading is through an insulated
access tube reaching through the insulation at the top and extending
almost to the bottom.  This may be adequate: again, only trials will
tell for sure.

On the desirability of mass storage (page 2 only of a letter, no name
given): My second letter, Feb.  21, describes a system that could
handle a fair number of patients per cryostat.

On Steve Harris' suggestion of patient in foam block between air and
liquid nitrogen: This is similar, in part, to my letter of Feb. 21.

On the cracking of foam insulation near liquid nitrogen: We avoid
this, in our liquid nitrogen cool-down boxes, by not using continuous
or poured foam, but layers of 2-inch foam slabs, with glass wool
padding and caulking--Andy Zawacki's idea.  If cracks occur (which we
have not observed) they don't propagate more than 2 inches outward.

Long life--



Bob Ettinger

-----

Feb. 26, 1993

Michael Darwin
Cryovita taboratories
1220 E. Washington St.,#24
Colton CA 92324

Dear Mike--

Thanks for the information and comments.

Enclosed is a copy of some further ideas on storage near GT, which -
if I haven't made some blunder - might improve space utilization.

Your ideas sound 0.K., lthough I'm not too comfortable with the idea
of using something like ethyl chloride.

There are doubtless many workable approaches, varying in cost for a
given level of reliability.  But -- although we (CI) intend to proceed
with trials of the float version in a cylindrical cryostat -- some
fundamentals remain unclear to me.

For one thing, if the patient must be kept very close to a particular
temperature, and if that temperature varies with concentration of
glycerol (and other factors) it becomes very tough.  Even if you have
a good way of estimating the average glycerine concentration in the
body (brain), the local concentratioa within the body will surely vary
considerably, and some regions will be at the wrong temperature.

Even more basic is the question of estimating the bottom-line change
in the patient's chances.  Knowledgeable people think the reduction in
cracking is *significant* near GT; but even if it is 95%, there will
still remain 5% cracking, which could well require full-fledged
nanotech for repair.  If nanotech is (probably) both necessary and
sufficient for either procedure, then it becomes very hard to justify
the more expensive procedure, except for those rich enough to be
willing to pay a high premium for a marginal and possibly meaningless
improvement.

Similar remarks apply to the whole question of improvements in the
hypothermic phase (except as these relate to improvements in
cryoprotectant uptake).  We know that several people have fully
recovered after drowning in cold water, even after being under water
for 45 minutes or more.  In other words, with prompt topical cooling,
they made complete recovery with no prior medication or treatment of
any kind.  This appears to prove that - within the limits of these
examples, including the fact that they were initially healthy people
and the cooling was only moderate -- any treatment prior to or
coincident with death can have only marginal importance.  As far as I
know, in almost all cases the hypothermic damage is small, probably
trivial, compared with the cryothermic damage.  (This tends to be
borne out, among other things, by Suda's experiments, comparing his
first and second series.)

Nevertheless, we tend to think that our people should have the benefit
of all available options and be allowed to use their own judgment.
Hence Cryonics Institute hopes to provide anything that appears to
have a substantial potential for benefit, if it is practically
feasible for us.  This includes Trans Time's services and yours.  As
you know, we already have an agreement with Trans Time; if Cryovita
develops a proposal, or if Alcor does, for that matter -- we will
consider it.

Long life--



Bob Ettinger
-----

Rate This Message: http://www.cryonet.org/cgi-bin/rate.cgi?msg=1906